510(k) · Cleared
Recalled · 2005Solution Administration Set with 0.22 Micron High Pressure Extended Life Filter
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Baxter Healthcare Corp · FPA Set, Administration, Intravascular
Cleared on Feb 25, 1997 as substantially equivalent to K960466 (Abbott Laboratories, 1996) after an 84-day review. Its family tree reaches back 1 generation to 1996. 2 later devices descend from it. It has been recalled 5 times.
- Decided
- Feb 25, 1997
- Review
- 84 days
- Class
- Class II
- Product code
- FPA
- Recalls
- 5
- Predicates
- 1
Its longest line of descent runs back 1 generation to K960466 (1996). 2 later devices descend from it, 2 citing it directly.
- Root · 1 generation backK960466 Ivex-2 Extension Set with Y-Injection Site (Modification)Abbott Laboratories · 1996
- This deviceK964850 Solution Administration Set with 0.22 Micron High Pressure Extended…Baxter Healthcare Corp · 1997
- Descendant · cites it directly · 0 of its ownK153158 Solution Administration Sets with 0.2 Micron FilterBaxter Healthcare Corporation · 2015 · Recalled
- Descendant · cites it directly · 0 of its ownK994429 Venusa, LTD. Extension Set with FilterVenusa, Ltd. · 2000
Most influential descendants
Showing 2 of 2 · See allView FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K960466 | Ivex-2 Extension Set with Y-Injection Site (Modification) | Abbott Laboratories | 1996 | — |
| 0 (this device) | K964850 | Solution Administration Set with 0.22 Micron High Pressure Extended Life Filter | Baxter Healthcare Corp | 1997 | — |
| +1 | K153158 | Solution Administration Sets with 0.2 Micron Filter | Baxter Healthcare Corporation | 2015 | 2 |
| +1 | K994429 | Venusa, LTD. Extension Set with Filter | Venusa, Ltd. | 2000 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2000 | 1 | 0 |
| 2015 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in FPA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new FPA device
- #1 K243841 Sparta Infusion Set for Insulinscore 13.4 · 3 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K960466 | Ivex-2 Extension Set with Y-Injection Site (Modification)Summary page 1…istration of intravenous solutions. The filter is manufactured by Millipore and has been recently cleared for marketing in Abbott solution administration sets covered by K960466. Baxter will purchase the 0.22 micron filter from Millipore and incorporate it into currently marketed solution administration s… | 1996 |
| * | — | Baxter Solution Sets with 0.22 Micron Filter Named without a submission number |
What descends from it? (2)
2 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
Recalls of this device
| Date | Class | Recall | Root cause | Reason |
|---|---|---|---|---|
| Dec 15, 2005 | Not classified | Z-0641-06 | Other | The extension sets contain microbore female luers that may crack during use, resulting in leakage of medication or incomplete delivery of medication. |
| Dec 15, 2005 | Not classified | Z-0642-06 | Other | The extension sets contain microbore female luers that may crack during use, resulting in leakage of medication or incomplete delivery of medication. |
| Dec 15, 2005 | Not classified | Z-0652-06 | Other | The extension sets contain microbore female luers that may crack during use, resulting in leakage of medication or incomplete delivery of medication. |
| Jul 6, 2005 | Not classified | Z-1100-05 | Other | Leaks and disconnection between the bifurcated Y-site and the set tubing may occur and result in underdelivery of medication, blood loss, and a breach of the sterile fluid pathway. |
| Jul 16, 2003 | Not classified | Z-1153-03 | Other | There are possible pinholes or perforations in the set tubing, caused by damage that occurred during the packaging process. |
No ancestor or descendant has a Class I recall.
What does this lineage say?
How does its category compare?
All FPA devicesFPA Set, Administration, Intravascular: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · FPA
11in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · FPA
225in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · FPA
98in 2025
Class I (17 since 2007) Class II/III not classified
Adverse event reports per year · FPA
34,506in 2025
MAUDE reports naming product code FPA, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 16 | 75 | 17 | 1,499 |
| 2008 | 18 | 89 | 15 | 1,941 |
| 2009 | 10 | 166 | 166 | 2,512 |
| 2010 | 23 | 120 | 58 | 2,537 |
| 2011 | 12 | 87 | 28 | 4,407 |
| 2012 | 21 | 96 | 16 (4) | 4,930 |
| 2013 | 13 | 90 | 64 | 4,651 |
| 2014 | 22 | 89 | 24 | 4,695 |
| 2015 | 17 | 123 | 6 | 6,625 |
| 2016 | 12 | 195 | 10 | 8,470 |
| 2017 | 17 | 240 | 13 | 6,462 |
| 2018 | 4 | 177 | 4 | 6,574 |
| 2019 | 7 | 161 | 13 | 11,227 |
| 2020 | 10 | 327 | 107 | 9,563 |
| 2021 | 13 | 186 | 1 | 10,414 |
| 2022 | 14 | 213 | 9 (5) | 13,393 |
| 2023 | 14 | 340 | 12 (4) | 10,916 |
| 2024 | 7 | 244 | 13 (1) | 47,210 |
| 2025 | 11 | 225 | 98 (1) | 34,506 |
| 2026 | 5 | 266 | 10 (2) | — |
What is it indicated for?
The subject of this submission is the Millipore 0.22 micron filter which Baxter intends to incorporate into various configurations of solution sets for the administration of intravenous solutions.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K964850 · printed Nov 4, 2026
Cite this page
510(k) Report. “K964850: Solution Administration Set with 0.22 Micron High Pressure Extended Life Filter.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K964850
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026